Profound Medical CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Profound Medical Corp. reported a 62% increase in revenue for the first six months of 2026, driven by strong capital equipment sales, while operating expenses decreased.
NASDAQ
Profound Medical Corp. reported significant revenue growth in Q3 2025, but faces a material uncertainty regarding its ability to continue as a going concern due to declining cash and projected debt covenant breach.
NASDAQ
Profound Medical Corp. reported a significantly wider net loss for Q2 2025, driven by substantial increases in operating expenses, despite revenue growth for the six-month period.
NASDAQ
Profound Medical Corp. saw an 82% increase in revenue in Q1 2025, driven by higher recurring revenue in the United States and capital sales overseas.